Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer

Neutropenia is the most frequent dose-limiting toxicity reported in patients with metastatic breast cancer receiving palbociclib. The objective of this study was to investigate the pharmacokinetic–pharmacodynamic (PK/PD) relationships for toxicity (i.e., absolute neutrophil count, ANC) and efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Courlet, Perrine, Cardoso, Evelina, Bandiera, Carole, Stravodimou, Athina, Zurcher, Jean-Philippe, Chtioui, Haithem, Locatelli, Isabella, Decosterd, Laurent Arthur, Darnaud, Léa, Blanchet, Benoit, Alexandre, Jérôme, Wagner, Anna Dorothea, Zaman, Khalil, Schneider, Marie Paule, Guidi, Monia, Csajka, Chantal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322950/
https://www.ncbi.nlm.nih.gov/pubmed/35890213
http://dx.doi.org/10.3390/pharmaceutics14071317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322950/
https://www.ncbi.nlm.nih.gov/pubmed/35890213
http://dx.doi.org/10.3390/pharmaceutics14071317

Ejemplares similares